• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Neural network measures MS disease progression

Article

The percentage of brain volume is an important marker of disease progression in multiple sclerosis. Researchers have developed a prototype neural network-based quantification system to measure this important benchmark by computer-assisted segmentation of multispectral MR imaging data.

The percentage of brain volume is an important marker of disease progression in multiple sclerosis. Researchers have developed a prototype neural network-based quantification system to measure this important benchmark by computer-assisted segmentation of multispectral MR imaging data.

Dr. Axel Wismueller of Ludwig Maximilians University in Munich performed MR exams in six women with relapsing-remitting MS. The neural network computed the percentage of brain volume by automatic cerebrospinal fluid segmentation. The voxel-specific gray-level intensity spectrum forms a seven-dimensional feature vector, which is classified by the neural network as either belonging to CSF or not. Findings were reported at the 2005 European Congress of Radiology.

The neural network-based computation significantly outperformed the conventional angle-image method. Specifically, the neural network performed better by retrieving only T2-weighted and perfusion/diffusion-weighted signals, thereby avoiding misclassifications in white matter lesions that are difficult to distinguish from CSF.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.